DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma

Human Pathology

Volumn 27, Issue 7, 1996, Pages 676-682

  Pich, A ^a   Margaria, E ^a   Chiusa, L ^a   Ponti, R ^a   Geuna, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

DNA ploidy; male breast carcinoma; p53 expression; prognosis; proliferative activity

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME NOR; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PLOIDY; PROGNOSIS;

EID: 0029955241     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90397-4     Document Type: Article

References (66)

1. FA Tavassoli Male breast lesions FA Tavassoli Pathology of the Breast 1992 Appleton & Lange Norwalk, CT 637 659
2. HJ Norris HB Taylor Carcinoma of the male breast Cancer 23 1969 1428 1435
3. G Ribeiro Male breast cancer: Review of 301 cases from Christie Hospital and Holt Radiun Institute, Manchester Br J Cancer 51 1985 115 119
4. B Salvadori R Saccozzi A Manzari Prognosis of breast cancer in males: An analysis of 170 cases Eur J Cancer 30 1994 930 935
5. LP Pertschuk DS Kim K Nayer Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies: Histopathologic, demographic and biochemical correlations and relationship to endocrine response and survival Cancer 66 1990 1663 1670
6. S Rogers CA Day SB Fox Expression of cathepsin D and estrogen receptor in male breast carcinoma Hum Pathol 24 1993 148 151
7. A Pich E Margaria L Chiusa Proliferative activity is a significant prognostic factor in male breast carcinoma Am J Pathol 145 1994 481 489
8. DW Hedley CA Rugg RD Gelber Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer Cancer Res 47 1987 4729 4735
9. O-P Kallioniemi G Blanco M Alavaikko Tumor DNA ploidy as an independent prognostic factor in breast cancer Br J Cancer 56 1987 637 642
10. J Yuan C Hennessy IP Corbett Node negative breast cancer: The prognostic value of DNA ploidy for long-term survival Br J Surg 78 1991 844 848
11. SM O'Reilly RS Camplejohn DM Barnes DNA index, S-phase fraction, histological grade and prognosis in breast cancer Br J Cancer 61 1990 671 674
12. PD Stanton TG Cooke SJ Uakes Lack of prognostic significance of DNA ploidy and S-phase fraction in breast cancer Br J Cancer 66 1992 925 929
13. TE Witzig JN Ingle SS Cha DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer Cancer 74 1994 1752 1761
14. JG Batsakis N Sneige AK El-Naggar Flow cytometric (DNA content and S-phase fraction) analysis of breast cancer Cancer 71 1993 2151 2153
15. P Gattuso VB Reddy L Green Prognostic significance of DNA ploidy in male breast carcinoma: A retrospective analysis of 32 cases Cancer 70 1992 777 780
16. T Hatschek S Wingren J Cartensen DNA content and S-phase fraction in male breast carcinomas Acta Oncol 33 1994 609 613
17. JM Nigro SJ Baker AC Preisinger Mutations in the p53 gene occur in diverse human tumour types Nature 342 1989 705 708
18. AJ Levine J Momand CA Finlay The p53 tumour suppressor gene Nature 351 1991 453 456
19. BM Kerns PA Jordan MBH Moore p53 Overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry J Histochem Cytochem 40 1992 1047 1051
20. AD Thor DH Moore II SM Edgerton Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancers J Natl Cancer Inst 84 1992 845 855
21. DM Barnes EA Dublin CJ Fisher Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Hum Pathol 24 1993 469 476
22. P Lipponen H Ji S Aaltomaa p53 Protein expression in breast cancer as related to histopathological characteristics and prognosis Int J Cancer 55 1993 51 56
23. V Bhargava A Thor G Deng The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer Mod Pathol 7 1994 361 368
24. Y Umekita T Takasaki H Yoshida Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: An immunohistochemical study Virchows Arch 424 1994 491 494
25. J Isola T Visakorpi K Holli Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients J Natl Cancer Inst 84 1992 1109 1114
26. TI Andersen R Holm JM Nesland Prognostic significance of TP53 alterations in breast carcinoma Br J Cancer 68 1993 540 548
27. R Silvestrini E Benini MG Daidone p53 As an independent prognostic marker in lymph node-negative breast cancer patients J Natl Cancer Inst 85 1993 965 970
28. A Anelli TFM Anelli B Youngson Mutations of the p53 gene in male breast cancer Cancer 75 1995 2233 2238
29. D Ploton M Menager P Jeannesson Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level Histochem J 18 1986 5 14
30. M Derenzini V Sirri D Trerè Nucleolar organizer regions in tumor cells Cancer J 7 1994 71 77
31. MB Mathews RM Bernstein BR Franza Identity of the proliferating cell nuclear antigen and cyclin Nature 303 1984 374 376
32. PA Hall DA Levison AL Woods Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms J Pathol 162 1990 285 294
33. S Aaltomaa P Lipponen S Papinaho Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer J Cancer Res Clin Oncol 119 1993 288 294
34. G Cattoretti MHG Becker G Key Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections J Pathol 168 1992 357 363
35. RW Scarff H Torloni Histological typing of breast tumours ed 4 International histological classification of tumours 1968 World Health Organization Geneva, Switzerland (no. 2)
36. P Hermanek LH Sobin TNM Classification of Malignant Tumours ed 4 1992 Springer-Verlag New York, NY
37. HJG Bloom WW Richardson Histological grading and prognosis in breast cancer Br J Cancer 11 1957 359 377
38. DW Hedley ML Friedlander IW Taylor Method for analysis of cellular DNA content of paraffin-embedded pathologic material using flow cytometry J Histochem Cytochem 31 1983 1333 1335
39. H Joensuu PJ Klemi Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma Am J Clin Pathol 89 1988 35 40
40. A Pich P Pisani M Krengli Argyrophilic nucleolar organizer region counts and prognosis in pharyngeal carcinoma Br J Cancer 64 1991 327 332
41. O Hiort PWL Kwan RA Delellis Immunohistochemistry of estrogen receptor protein in paraffin sections Am J Clin Pathol 90 1988 559 563
42. EL Kaplan P Meier Nonparametric estimation for incomplete observations J Am Stat Assoc 53 1958 457 481
43. DR Cox Regression models and life tables (with discussion) J R Stat (Series B) 34 1972 187 220
44. WJ Dixon MB Brown L Engelman BMDP Statistical Software Manual 1990 University of California Press Berkeley, CA
45. B Fisher N Gunduz J Costantino DNA flow cytometric analysis of primary operable breast cancer: Relation of ploidy and 5-phase fraction to outcome of patients in NSABP B-04 Cancer 68 1991 1465 1475
46. KY Erhardt GV Aver Mammary carcinoma comparison of nuclear DNA content from in-situ and infiltrative components Anal Quant Cytol 9 1987 263 267
47. TE Kute HB Muss D Anderson Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer Cancer Res 41 1981 3524 3529
48. DW Visscher RJ Zarbo G Jacobsen Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry Lab Invest 62 1990 370 378
49. JE Fuhr A Frye AA Kattine Flow cytometric determination of breast tumour heterogeneity Cancer 67 1991 1401 1405
50. LG Koss B Czerniak T Herz Flow cytometric measurements of DNA and other cell components in human tumors: A critical appraisal Hum Pathol 20 1989 528 548
51. WA Mourad B Erkman-Balis S Livingston Argyrophilic nucleolar organizer regions in breast carcinoma: Correlation with DNA flow cytometry, histopathology, and lymph node status Cancer 69 1992 1739 1744
52. S Aaltomaa P Lipponen K Syrjanen Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer Pathol Res Pract 189 1993 416 421
53. J Rüschoff K Neumann H Contractor Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: Correlation with DNA content, proliferation rate, receptor status and histopathological grading J Cancer Res Clin Oncol 116 1990 480 485
54. PK Lipponen MJ Eskelinen S Nordling Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer Br J Cancer 64 1991 1139 1144
55. A Pich R Chiarle L Chiusa Long-term survival of thymoma patients by histologic pattern and proliferative activity Am J Surg Pathol 19 1995 918 926
56. M Trudel L Mulligan W Cavenee Retinoblastoma and p53 gene product expression in breast carcinoma: Immunohistochemical analysis and clinicopathologic correlation Hum Pathol 23 1992 1388 1394
57. CM Barton SL Staddon CM Hughes Abnormalities of the p53 suppressor gene in human pancreatic cancer Br J Cancer 64 1991 1076 1082
58. RA Walker SJ Dearing DP Lane Expression of p53 protein in infiltrating and in-situ breast carcinomas J Pathol 165 1991 203 211
59. HA Lambkin CM Mothersill P Kelehan Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection J Pathol 172 1994 13 18
60. S Bosari G Viale U Radaelli p53 Accumulation in ovarian carcinomas and its prognostic implications Hum Pathol 24 1993 1175 1179
61. P Lipponen M Eskelinen K Hietala Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma Int J Cancer 57 1994 275 280
62. JL Frank ME Burt JL Garb p53 Tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx Cancer 73 1994 181 186
63. DC Allred GM Clark R Elledge Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer J Natl Cancer Inst 85 1993 200 206
64. PA Hall DP Lane p53 In tumour pathology: Can we trust immunohistochemistry? Revisited! J Pathol 172 1994 1 4 (editorial)
65. G Cattoretti F Rilke S Andreola p53 expression in breast cancer Int J Cancer 41 1988 178 183
66. T Suzuki Y Takano Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas Jpn J Cancer Res 84 1993 1072 1077